Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Euronext Bruxelles  >  Agfa-Gevaert    AGFB   BE0003755692

SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 

AGFA-GEVAERT : Annual General Meeting of Agfa-Gevaert

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/24/2012 | 02:31pm CEST
  • Press Release
  • Mortsel (Belgium)
  • April 24, 2012 02:00

At Agfa-Gevaert's Annual General Meeting today, all the voting points on the agenda were approved. These included the approval of the 2011 financial statements, the allocation of the result as well as the discharge of directors and auditors.

The shareholders also approved the reappointment of De Wilde J Management BVBA, with permanent representative Julien De Wilde, and Christian Leysen as members of the Board of Directors. Finally, the General Meeting resolved, in accordance with article 556 of the Companies Code, to approve the change-of-control provisions, as stipulated in the Facility Agreement dated May 31, 2011 with Fortis Bank SA/NV, ING Belgium SA/NV and KBC Bank NV on the one hand and Agfa HealthCare NV, Agfa Graphics NV and Agfa-Gevaert NV on the other hand.

At the consequent Extraordinary General Meeting today - all the voting points on the agenda, all of them regarding changes in the articles of association - were approved, except for voting point n°3 regarding the spread in time of the variable remuneration.


Viviane Dictus
Director Corporate Communication
Septestraat 27
2640 Mortsel - Belgium
tel+32 (0) 3 444 7124
fax+32 (0) 3 444 4485
[email protected]
Johan Jacobs
Corporate Press Relations Manager
Septestraat 27
2640 Mortsel - Belgium
tel+32 (0) 3 444 8015
fax+32 (0) 3 444 4485
[email protected]
distributed by
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on AGFA-GEVAERT
06/23 Global Thermal CTP Plate Market 2017- Kodak, Fujifilm, Mitsubishi Imaging, AG..
06/20 AGFA GEVAERT : Special Notice - Radiology Workstation and AGFA Licences
06/15 AGFA GEVAERT : unveils its new UV LED Jeti Tauro printers at Fespa 2017
05/18 AGFA GEVAERT : Sources Sought Notice - J-- AGFA Radiology Printers Maintenance a..
05/15 AGFA GEVAERT : Publication of a transparency notification – Regulated info..
05/15 AGFA-GEVAERT : Publication of a transparency notification - Regulated informatio..
05/11 AGFA GEVAERT : $59,184 Federal Contract Awarded to AGFA Healthcare
05/09 AGFA GEVAERT : Jaarlijkse Algemene Aandeelhoudersvergadering van Agfa-Gevaert NV
05/09 AGFA GEVAERT : Annual General Meeting of Agfa-Gevaert NV
05/09 AGFA-GEVAERT PUBLISHES ITS FIRST QUA : 45 a.m. CET
More news
Sector news : Advanced Medical Equipment & Technology - NEC
06/28 Philips to buy medical device maker Spectranetics for 1.9 billion euros
06/28DJROYAL PHILIPS : to Buy Spectranetics for $2.15 Billion
06/22DJROYAL PHILIPS : Philips to Buy Electrical Geodesics for GBP29 Million
06/19 PERKINELMER : to buy Germany's Euroimmun for about $1.3 billion
05/23DJFirms Persuade SEC on Profit Metric -- WSJ
More sector news : Advanced Medical Equipment & Technology - NEC
News from SeekingAlpha
05/09 Agfa-Gavaert NV reports Q1 results
03/08 Agfa-Gavaert's (AFGVF) CEO Christian Reinaudo on Q4 2016 Results - Earnings C..
03/08 Agfa-Gavaert NV reports Q4 results
03/08 Agfa-Gavaert NV 2016 Q4 - Results - Earnings Call Slides
2016 Agfa-Gavaert's (AFGVF) CEO Christian Reinaudo on Q1 2017 Results - Earnings C..
Advertisement
Financials (€)
Sales 2017 2 513 M
EBIT 2017 -
Net income 2017 81,0 M
Debt 2017 -
Yield 2017 -
P/E ratio 2017 -
P/E ratio 2018
Capi. / Sales 2017 0,30x
Capi. / Sales 2018 0,30x
Capitalization 754 M
More Financials
Chart AGFA-GEVAERT
Duration : Period :
Agfa-Gevaert Technical Analysis Chart | AGFB | BE0003755692 | 4-Traders
Full-screen chart
Technical analysis trends AGFA-GEVAERT
Short TermMid-TermLong Term
TrendsBullishNeutralBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 2
Average target price 4,20 €
Spread / Average Target -4,3%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Christian Reinaudo President, Chief Executive Officer & Director
Julien de Wilde Chairman
Kris Hoornaert Chief Financial Officer
Jozef Cornu Non-Executive Director
Willy W. Duron Independent Non-Executive Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
AGFA-GEVAERT20.94%856
THERMO FISHER SCIENTIF..23.10%67 955
DANAHER8.84%59 950
BOSTON SCIENTIFIC CORP..30.00%38 083
ROYAL PHILIPS12.21%34 752
INTUITIVE SURGICAL49.22%34 483
More Results